Physician profile
Fernando A Yepes
NPI 1366607624
$2,440.89
in general payments reported to CMS, 2019-2025
8 companies · $2,062 in 2025
The $2,062 reported for 2025 was more than what 93% of Critical Care Medicine (Anesthesiology) providers received nationally (typical 2025 total: $97.90).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2021: $24.60 · 2023: $50.96 · 2024: $160 · 2025: $2,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,345 · Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,344.51 |
| Food and Beverage | $928.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,709.82 | 2025 | Pascal, Sapien 3 Ultra Resilia |
| Becton, Dickinson and Company | $330.25 | 2025 | Swan-Ganz, Hemosphere |
| Abiomed | $159.89 | 2024 | Impella |
| Pharming Healthcare, INC. | $125.00 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $50.96 | 2023 | Fasenra |
| Siemens Medical Solutions USA, INC. | $24.60 | 2021 | |
| Merck Sharp & Dohme LLC | $22.18 | 2025 | Bridion |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Yepes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.